Anika Therapeutics, Inc. Share Price
Stocks
ANIK
US0352551081
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 21.42 USD | +1.56% |
|
+7.21% | +122.89% |
| 09-18 | B. Riley Adjusts Anika Therapeutics Price Target to $23 From $21, Maintains Buy Rating | MT |
| 07-30 | B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating | MT |
| Market Cap | 287M 256M 236M 214M 401M 27.21B 408M 2.85B 1.13B 14.26B 1.08B 1.05B 44.95B | P/E 2026 * |
612x | P/E 2027 * | 71.4x |
|---|---|---|---|---|---|
| Enterprise Value | 287M 256M 236M 214M 401M 27.21B 408M 2.85B 1.13B 14.26B 1.08B 1.05B 44.95B | EV / Sales 2026 * |
2.36x | EV / Sales 2027 * | 2.24x |
| Free-Float |
79.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANIK | Delayed | |
CBOE
| ANIK | Real-time | |
|
Deutsche Boerse AG
| AKP | Delayed | |
|
Börse Stuttgart
| AKP | Delayed | |
|
Berne S.E.
| AKP | End-of-day quote | |
|
Boerse Muenchen
| AKP | Real-time |
Last Transcript: Anika Therapeutics, Inc.
| 1 day | +1.56% | ||
| 1 week | +7.21% | ||
| Current month | +8.95% | ||
| 1 month | +5.13% | ||
| 3 months | +46.01% | ||
| 6 months | +38.91% | ||
| Current year | +122.89% |
| 1 week | 19.87 |  | 21.45 |
| 1 month | 18.11 | | 21.45 |
| Current year | 9.01 | | 22.88 |
| 1 year | 9.01 | | 22.88 |
| 3 years | 7.87 | | 29.12 |
| 5 years | 7.87 | | 45.81 |
| 10 years | 7.87 | | 75.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Griffin
CEO | Chief Executive Officer | 41 | 31/01/2026 |
Dawn Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2023 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 13/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheryl Blanchard
CHM | Chairman | 62 | 31/01/2026 |
John Henneman
CHM | Chairman | 65 | 23/02/2024 |
Stephen Richard
BRD | Director/Board Member | 64 | 02/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/08/26 | Buy | Director | 1,000 | 0.0075% | ||
| 03/06/26 | Exercice | Chief Executive Officer | 29,449 | 0.2213% | ||
| 01/05/26 | Buy | Director | 5,000 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +7.21% | +121.97% | +15.16% | 287M | |
| +1.16% | -1.13% | -17.92% | +8.27% | 179B | |
| +0.02% | +4.24% | -19.82% | +16.53% | 118B | |
| -1.22% | +0.70% | +1.27% | +31.80% | 117B | |
| +2.29% | +17.36% | -41.94% | +9.49% | 93.26B | |
| -2.21% | -2.91% | +0.74% | +75.30% | 63.16B | |
| -1.06% | +1.75% | +13.50% | +80.00% | 55.68B | |
| -0.75% | +3.73% | +6.64% | -22.28% | 54.18B | |
| -1.13% | +0.00% | -12.25% | +31.02% | 44.15B | |
| +0.17% | +5.85% | -4.92% | -10.64% | 33.95B | |
| Average | -0.12% | +3.44% | +4.73% | +23.46% | 75.87B | |
| Weighted average by Cap. | -0.00% | +3.09% | -11.63% | +22.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 122M 109M 100M 90.94M 170M 11.55B 173M 1.21B 478M 6.05B 457M 447M 19.07B | 128M 115M 106M 95.89M 179M 12.18B 182M 1.27B 504M 6.38B 481M 471M 20.11B |
| Net income | 482K 431K 398K 361K 675K 45.8M 686K 4.79M 1.9M 24M 1.81M 1.77M 75.66M | 4.17M 3.73M 3.44M 3.12M 5.84M 396M 5.93M 41.43M 16.4M 208M 15.66M 15.33M 654M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | US$21.42 | +1.56% | 59,202 |
| 22/10/26 | US$21.09 | +2.38% | 61,425 |
| 21/10/26 | US$20.60 | +0.78% | 51,291 |
| 20/10/26 | US$20.44 | +1.09% | 362,961 |
| 19/10/26 | US$20.22 | +1.20% | 66,535 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIK Stock
Select your edition
All financial news and data tailored to specific country editions
